## Objective: This study was designed to evaluate the potential efficacy of repetitive transcranial magnetic stimulation (rtms) at low-frequency in patients with major depression and schizophrenia. ## Experimental design: We investigated the therapeutic effect of a course of 10 rtms sessions in 1
A randomized clinical trial of repetitive transcranial magnetic stimulation in patients with refractory epilepsy
β Scribed by Felipe Fregni; Patricia T.M. Otachi; Angela Do Valle; Paulo S. Boggio; Gregor Thut; Sergio P. Rigonatti; Alvaro Pascual-Leone; Kette D. Valente
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 137 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objective
To study the antiepileptic effects of rTMS in patients with refractory epilepsy and malformations of cortical development in a randomized, doubleβblind, shamβcontrolled trial.
Methods
Twentyβone patients with malformations of cortical development and refractory epilepsy underwent five consecutive sessions of lowβfrequency rTMS, either sham or active (1Hz, 1,200 pulses), focally targeting the malformations of cortical development. The number of epileptiform discharges in the electroencephalogram and the number of clinical seizures were measured before (baseline), immediately after, as well as 30 and 60 days after rTMS treatment.
Results
rTMS significantly decreased the number of seizures in the active compared with sham rTMS group (p < 0.0001), and this effect lasted for at least 2 months. Furthermore, there was a significant decrease in the number of epileptiform discharges immediately after (p = 0.01) and at week 4 (p = 0.03) in the active rTMS group only. There were few mild adverse effects equally distributed in both groups. The preliminary cognitive evaluation suggests improvement in some aspects of cognition in the active rTMS group only.
Interpretation
Noninvasive brain stimulation for epilepsy may be an alternative treatment for pharmacoβresistant patients with clearly identifiable seizure foci in the cortical convexity and who are not eligible for surgical treatment. Ann Neurol 2006;60:447β455
π SIMILAR VOLUMES
## Abstract ## Background The aim was to determine whether folate supplementation improved arterial function in patients with peripheral arterial disease (PAD). ## Methods Individuals with PAD were randomly assigned to receive 400 Β΅g folic acid (45 patients) or 5-methyltetrahydrofolate (5-MTHF)
## Background: Ifosfamide and paclitaxel are antineoplastic agents with broad activity and with different mechanisms of action. a phase i trial was conducted to determine the maximum tolerated dose and associated toxicities of these agents when used in combination. ## Methods: Patients with refra